The v-myc oncogene was first identified as that portion of the avian myelocytomatosis virus MC29 genome responsible for its ability to rapidly induce neoplastic disease (43, 48) . As is the case with other retroviral oncogenes, v-myc was acquired by viral transduction of a homologous host cellular sequence (c-myc) through an as yet undefined mechanism. Retroviral interactions with myc produce a broad range of neoplasias, including myelocytomas, endotheliomas, and carcinomas induced by MC29 or other myc-containing retroviruses (20) and B-cell lymphomas induced by the insertion of avian leukosis virus near the host c-myc locus (25) . Interest in myc has been further stimulated by its apparent involvement in cancers which do not have a retroviral etiology. These include Burkitt's lymphomas and murine plasmacytomas, where specific chromosomal translocations involving myc occur (51) , and leukemias, carcinomas, and neuroblastomas, where amplification of the c-myc locus or the c-myc-related sequence N-myc occurs (2, 10, 28, 47) . The spectrum of malignancies in which myc has been implicated suggests that it may play a very basic role in oncogenesis.
Investigations of myc gene products have shown that the mature protein is localized in the nucleus and has DNA-binding activity (14, 23, 38) . The c-myc gene is expressed in a variety of cell types (49) . Levels of expression are low in quiescent cells but elevated during cell proliferation, and they are modulated in a cell cycle-specific manner (27) . Expression of c-myc can be induced by platelet-derived growth factor, and myc proteins may play a role in mediating the mitogenic effects of this growth factor (3). These results suggest that c-myc normally functions in the control of cell growth, perhaps by regulating the activity of other genes.
Recently, myc-containing feline leukemia virus (mycFeLV) proviruses have been identified in three independent studies of naturally occurring T-cell lymphosarcomas of cats (31, 33, 35) . Such recombinant proviruses were found in 8 of 32 T-cell tumors examined in these studies, suggesting that * Corresponding author. myc transduction or horizontal transmission of myc-FeLV is a common occurrence. Moreover, FeLV isolates containing at least five other oncogenes (fms, fes, fgr, sis, and abl) have been obtained from naturally occurring tumors (5, 6, 13, 19, 34) . These findings suggest that transduction of oncogenes by FeLV may play a significant role in the epidemiology of feline cancer.
To more clearly define the molecular mechanism by which myc-FeLV proviruses may induce T-cell neoplasia, we determined the nucleotide sequence of the feline v-myc gene and flanking FeLV sequences from the myc-FeLV molecular clone of Levy et al. (31) . In the present study we report that sequence, compare it to previously determined myc and FeLV sequences, and comment on several features which may be relevant to oncogenic activation of myc genes.
MATERIALS AND METHODS
The recombinant plasmid pBam8, which contains a fulllength copy of the myc-FeLV provirus isolated by Levy et al. (31) , was used for sequence analysis. Transient assays indicate that this provirus is transcribed after DNA transfection of tissue culture cells (M. Braun and J. Casey, unpublished data). Preliminary attempts to rescue the myc-FeLV provirus with replication-competent helper FeLV have been unsuccessful, but this may be due in part to the lack of a focus-forming assay in which the myc oncogene is active. The entire pBam8 plasmid was sonicated to produce a random assortment of fragments. The fragments were end repaired and cloned in the SmaI site of the M13mp8 vector (32) to produce a random or "shotgun" sequencing library (11) . Clones containing myc-related sequences were selected by their ability to hybridize with the radiolabeled 1.5-kilobase PstI fragment of chicken v-myc (1). A total of 26 myc-hybridizing clones were isolated and sequenced by the Sanger dideoxy nucleotide method (7, 12, 45) to derive the 1,744-base-pair (bp) feline v-myc sequence (plus flanking sequences) shown in Fig. 1 . The entire sequence was determined completely on both strands of DNA. The high guanineplus-cytosine (G+C) content of the myc gene caused an 178   BRAUN ET AL.   ST  C  G  GA   FV GCA GGT AGG GAG CAC CTA CGC CTT TAT CGC CAG TTG CTA TTA GCG GGT CTC CGC GGG GCT GCA AGA CGC CCC ACT AAT TTG GCA CAG GTAMAG CMAGTT 99 Ala Gly Arg Giu His Leu Arg Leu Tyr Arg Gin Lea Leu Lea Ala Giy Leu Arg Gly Ala Ala Arg Arg Pro Thr Asn Leu Ala Gin Val Lys Gin Val   H   T   C  A A  A ACG  G A  A  C A   H~~~~~~~~~A C C  ACG  T  A  FV GTA CMA GGG ATA GTG GMA AAC CCG CAG GCT GCC GCG --ATG CCC CTC AAC GTC AGC TTC GCC AAC AGG AAC TAT GAC CTC GAC TAC GAC TCG GTG CAG HA  A  T  T C  A  C  T  H  G  C   FV CCC TAT TiC TAC TGC GAC GAG GAG GAG MC TTC TAC CAG CAG CAG CAG CAG AGC GAG CTG CAG CCG CCG GCG CCC AGC GAG GAT ATC TGG MAG AMA TTC Gin Lys Asp Len Len Arg Lys Arg Arg Gin Gin Len Lys His Lys Len Gin Gin Len Arg Ass Ser Cys Ala ENS (Fig. 2) . The 5' junction between myc and FeLV occurs at nucleotide 109 ( Fig. 1) , which corresponds to nucleotide 1592 of the FeLV gag gene (30) . FeLV sequences coding for 103 amino acids of the gag p30 protein, the entire gag plO protein, the entire RNA-dependent DNA polymerase (pol) gene, and a portion of the envelope (env) gene have been deleted from myc-FeLV. Homology to mammalian c-myc sequences begins immediately after the myc-FeLV junction with a 26-bp segment corresponding to untranslated myc leader, which is followed by the c-myc coding sequence. Assuming that the splice junctions of feline c-myc are the same as those of the human and murine genes, 14 bp of this leader sequence are derived from exon 1, and 12 bp are derived from exon 2 (Fig. 2) . The majority of exon 1, which comprises an unusually long untranslated region in mouse and human c-myc, has not been transduced into feline v-myc. The myc reading frame is in phase with that of gag, and there are no termination codons in the short myc leader; therefore, it is plausible that v-myc is expressed as a gag fusion protein, a common pattern among defective retroviruses containing oncogenes.
The open reading frame for feline v-myc continues until the termination codon beginning at nucleotide 1453. This codon is followed by 99 bp homologous to the 3' untranslated region of both mouse and human c-myc (Fig. 1) . The 3' myc-FeLV junction occurs at position 1554 of our sequence, where homology to FeLV resumes within the env gene. The first 443 bp of env have been deleted. Significantly, no polyadenylation signal (AATAAA) is included in the portion of myc which has been transduced. Such a signal occurs in mouse and human c-myc genes 200 to 230 bp beyond the 3' point of myc-FeLV fusion (4) . Polyadenylation signals are also missing from the v-myc gene of MC29 and the v-onc genes of several other acutely transforming retroviruses (42) .
The lack of a polyadenylation signal probably allows transcription of a full-length copy of the defective provirus, which presumably is required for it to be infectious.
Three restriction endonuclease sites (two SacII and one PstI) that did not appear in a previously published map (31) were predicted by the nucleotide sequence. All of these were sufficiently close to other SacII or PstI sites to be below the limits of resolution of the mapping study, and all have been confirmed experimentally (see above).
Comparative sequente analysis of myc genes. The portion of feline v-myc homologous to the coding sequences of muritle and human c-myc has been highly conserved during evolution ( Fig. 1 and 3) . All three coding sequences are 1,317 bp long. The cat and human genes are colinear, whereas the mouse sequence has one 3-bp deletion and one 3-bp insertion. At the nucleotide level, there are 109 substitutions between cat and human (92% identity). The number of substitutions between mouse and cat (153; 88.4% identity) and mouse and human (158; 88% identity) are similar, both being approximately 40% larger than the number of substitutions between cat and human.
Homology among the feline, murine, and human myc genes is also extensive at the amino acid level (Fig. 3) . There are 30 amino acid replacements between cat and human, 34 between cat and mouse, and 38 between mouse and human for a total of 47 variable positions in the 439-amino-acid sequence. The percent identity in these comparisons ranges from 91 to 93%. Furthermore, many replacements are conservative; only 10 result in charge changes (Fig. 3) . It has previously been observed that, when compared to chicken c-myc, exon 3 is more conserved in mouse and human c-myc than is exon 2 (4), and this observation extends in a general way to the feline v-myc sequence. Furthermore, with three mammalian myc genes for comparison, it becomes clear that the majority of amino acid replacements among the mammalian genes are confined to five variable regions (Fig. 3) . These five regions account for 27 of 47 variable positions (57%) but include only 54 of 439 residues (12%). Two of these regions have been deleted from chicken c-myc, and two others show little sequence conservation between avian and mammalian myc homologs, suggesting that exact sequence conservation in these regions is not critical to myc function. Otne of the variable regions overlaps the prolinerich area of chicken myc (amino acids 156 to 170, Fig. 3 ). It has been speculated that this proline-rich segment would provide a flexible bridge that might link two functional domains of the myc protein (42) . Lack of sequence conservation discourages attributing the same function to this region of the mammalian myc proteins.
The 26-bp 5' myc leader sequence and 102-bp 3' myc untranslated sequence which appear in myc-FeLV can be aligned with comparable portions of murine and human c-myc sequences (Fig. 1) . The similarity between these sequences is obvious, with 69 to 88% identity in the 5' leader and 68 to 79% identity in the 3' untranslated region (deletions not included). Therefore, we assume that these sequences are derived from the corresponding portions of feline c-myc. The high degree of sequence conservation in these untrans- segment is identical to a 109-bp sequence in the p30 region of FeLV sequences. The FeLV-related portions of the mycthe gag gene of Gardner-Arnstein feline sarcoma virus FeLV sequence are very similar to previously reported (GA-FeSV), and it has only three nucleotide substitutions
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************ * * ***************** ****** *** * * * *** ** *** *********** ******************** ** ********************* *********** *************** * **** *** * *** ** *************** * (Fig. 1) . In the 190-bp env-related segment, there are three nucleotide substitutions and a 2-bp insertion with respect to GA-FeLV env and two nucleotide substitutions and a 1-bp insertion with respect to ST-FeLV env. Sequence identity between myc-FeLV and GA-FeLV is therefore somewhat greater than that between myc-FeLV and STFeLV in the 300 bp where they can be compared. Taken together with sequence data from the long terminal repeat (Braun and Casey, unpublished data), where myc-FeLV is once again more similar to GA-FeLV than ST-FeLV, these data confirm the earlier conclusion based on restriction enzyme site mapping that this myc-FeLV isolate was derived from a GA-FeLV-like ancestor (31) .
The fact that the two small insertions in the myc-FeLV and ST-FeLV env genes both occur at the same site is surprising and suggests that this site may be prone to insertion-deletion events. Both insertions involve the addition of adenosine residues to a run of adenosines already seven residues long (Fig. 1) . Runs of adenosines have previously been identified as mutational hot spots in other systems, such as the lysozyme gene of bacteriophage T4 (37) and the mitochondrial DNA of Rattus norvegicus (G. G. Brown, R. Prussick, and R. J. Desrosiers, Genetics 104:9-10, 1983). Such runs of a single base are thought to be prone to small insertion-deletion mutations because transient misalignments of the complementary strands can occur during DNA replication (15) .
In the present case, it is likely that neither of the two insertions was opposed by natural selection (even though they would cause frameshift and premature termination) because neither the myc-FeLV nor the ST-FeLV env genes are functional. The ST-FeLV clone from which the env sequence was derived is known to be noninfectious (36) , and myc-FeLV could only replicate with the aid of helper virus. The possibility exists that these insertions could have occurred during cloning. This example suggests that caution should be exercised in interpreting DNA sequence data from molecular clones whose biological function has not been or cannot be tested.
FeLV-oncogene junctions. The 3' fusion points between FeLV sequences and oncogenes are remarkably similar in several defective FeLV proviruses (13) . The restriction maps of GA-FeSV, ST-FeSV, and McDonough FeSV all have PstI and XhoI sites in FeLV sequences immediately to the right of the 3' onc-FeLV junction, indicating that the same FeLV sequences may have been involved in all three recombinational events. The possibility that some sequence specificity exists in recombination between FeLV and oncogenes was brought sharply into focus when DNA sequencing revealed that the junctions between the 3' end of v-fes and FeLV are identical in ST-FeSV and GA-FeSV (22) . The identity of the junction in these two fes-containing isolates could also be explained if they originated from a single recombinational event and subsequently diverged, but two lines of evidence argue against this possibility. First, there are substantial differences in the organization of their gagfes fusion regions (22) . Second, the degree of sequence divergence between the gag genes of GA-FeSV and STFeSV is much greater than that between the gag genes of ST-FeSV and its natural helper virus (30) , a result that would be unexpected if both defective isolates originated from one transducing event.
In the present case, FeLV sequences immediately 3' to the myc-FeLV junction begin with the-same short direct repeat (CTCCTC) that is found 3' to the fes-FeLV junction in both ST-FeSV and GA-FeSV (22) . Given the similarity of FeLV sequences at the 3' onc-FeLV junctions discussed above, it is tempting to speculate that this viral hexanucleotide represents a preferred sequence which is in some way involved in the transduction of host sequences by FeLV. Sequence preference might occur if transduction arises as a side product of some normal mechanism such as viral replication or RNA processing. If such a sequence preference exists, however, it is not restricted to a unique viral location, since the 3' onc-FeLV junction in myc-FeLV occurs 443 nucleotides within the env gene, whereas those of ST-FeSV and GA-FeSV are apparently just 5' to the env gene (13) . Furthermore, the CTCCTC hexanucleotide is not an absolute requirement for transduction, since it is not present at the 3' fgr-FeLV junction in the Gardner-Rasheed feline sarcoma virus (34) . Nucleotide sequence analysis of other onc-FeLV junctions will be required to determine the actual frequency of the CTCCTC sequence at such junctions and its importance in the transduction of host sequences.
With regard to 5' fusion points between FeLV and oncogenes, little similarity has been evident in published restriction maps (13, 18, 31, 34, 35, 36) . However, the nucleotide sequence shows that the 5' fusion of myc-FeLV occurred 17 bp upstream of the 5' fusion in GA-FeSV (22) . Again, full evaluation of this observation awaits comparative sequence data from other onc-FeLV junctions.
Mechanisms of myc activation. There are a number of viable models for mechanisms by which proto-oncogenes may be converted to oncogenes (8) . The most popular models are either quantitative (overexpression of an otherwise normal gene) or qualitative (mutations which alter the function of the gene). The most convincing evidence so far generated is for qualitative activation in the case of ras, where each of the known ras proto-oncogenes appears to be susceptible to activation by point mutations in codon 12 or 61 (46) . In the case of myc, quantitative models of activation have received more attention. Cellular myc genes come under the control of powerful promoters or enhancers in several types of tumors, and elevated levels of myc RNA have been found in some of these (see, for example, references 24 and 25) . Transgenic mice that carry a normal myc gene directed by control sequences of mouse mammary tumor virus show both elevated levels of myc expression in lactating breast tissue and a high propensity to develop breast cancer (50) . Since myc appears to be an intracellular mediator of cell proliferation (3), a link between myc overexpression and oncogenesis seems reasonable. However, other studies have suggested that the elevation of myc expression in several tumor cell lines is no greater than that seen in rapidly proliferating normal cells (21, 26) . In these cases point mutations, such as those observed in several v-myc and tumor-derived c-myc genes (39, 53, 55) , may contribute to oncogenesis.
We can make a preliminary assessment of the importance of point mutations for myc activation by looking for amino acid replacements which are common to several activated myc genes. Published sequences of v-myc from MC29 and chicken c-myc differ at five to seven predicted amino acids (Fig. 3) . If point mutations are solely responsible for myc activation, one or more of these residues must be involved. Although the feline c-myc sequence is not available, a comparison can be made between feline v-myc and those residues which are conserved in mouse and human c-myc. This comparison assumes that residues critical to normal myc function will be conserved in c-myc sequences. There 182 BRAUN ET AL.
are 16 positions at which feline v-myc differs from amino acid residues conserved in mouse and human c-myc (Fig. 3) . In no case do both feline and avian v-myc genes differ from the corresponding c-myc genes at homologous amino acid positions. Similar comparisons of feline v-myc with altered c-myc alleles from Raji cells (39) and bursal lymphoma LL3 (55) also reveal no replacements at homologous positions. We therefore conclude that myc activation does not depend upon point mutations at a unique site.
However, the possibility exists that there are multiple sites or regions of the molecule in which point mutations can cause myc activation. Especially intriguing is the observation that both feline and avian v-myc have lost potential phosphorylation sites of the type Lys/Arg-X-Ser/Thr (56) . Two of these sites are within five residues of each other (amino acid 343 of feline v-myc in Fig. 3 ). These potential phosphorylation sites occur within a region that is well conserved between avian and mammalian myc genes and shows hornology to the ElA protein of adenovirus (40) , a protein which is thought to have a function simnilar to myc (29, 44) . This region is known to be multiply phosphorylated in p11Vag`mYc, the transforming protein of MC29 (17, 41) . This same region is rich in basic amino acids and is thought to be involved in DNA binding by pllYa9-mYc (1). It can be envisioned that phosphorylation might regulate the DNAbinding activity of normal myc proteins by neutralizing a positively charged region of the protein. Loss of a potential phosphorylation site might result in a myc protein with a constitutively high affinity for DNA, which could alter its normal physiological function.
A second region where point mutations may be involved in myc activation is near position 58 of the mammalian amino acid sequence (Fig. 3) . Threonine is replaced by asparagine at this position in the altered allele of Raji cells and by methionine in chicken v-myc (39) . In the avian bursal lymphoma LL3, there is a proline-to-threonine transition two amino acids away (55) . Although these replacements could in theory represent normal polymorphisms, the fact that they occur in a region which is perfectly conserved in chicken, mouse, and human c-myc and feline v-myc makes this possibility unlikely.
The hypothesis that point mutations could cause myc activation does not conflict with the overexpression model. It is conceivable that the crucial change during myc activation is an overall increase in DNA binding by myc. Total DNA-binding activity would increase if either the number of myc molecules per cell increased (through overexpression) or the DNA affinity of each myc molecule increased (through point mutation). Thus, several distinct molecular mechanisms could cause the activation of the same oncogene.
Although the exact role of myc in the transformation process remains unknown, knowledge of the feline v-myc sequence will facilitate direct tests of the importance of point mutations, phosphorylation, and overexpression to myc activation in the feline system. 
